Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention

NCT00405717 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT00405717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00405717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
Lead sponsor
Shenyang Northern Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2006
Completion date
May 31, 2008
Enrollment
1,300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, ischemic heart disease